SHOUCHENG (697.HK) Siasun Robot&Automation Fund's investment book value has increased more than three times compared to the original, as Patient Capital leverages the trillion-dollar track.

Hong Kong, May 2, 2025 /PR Newswire/ -- On April 30, 2025, SHOUCHENG (697.HK), which is actively positioning itself in the Siasun Robot&Automation sector, held a media exchange meeting after its annual Shareholder meeting, where dozens of media outlets from Hong Kong and mainland China, along with the company's Shareholders and investors, gathered to engage in in-depth discussions with the company's management regarding the current status of the company's Business development and future strategic plans. At the same time, the company showcased multiple cutting-edge robot products for the first time in Hong Kong, including Universe Tree Technology, Star Sea Map, Silver Galaxy General, and Songyan Power, which became the focal point of the event, attracting significant attention from the industry and demonstrating the company's vision.

PR NewswireMay 2 05:11 ET

Shoucheng Holdings to Announce Q1 2025 Results

TipRanksMay 2 05:09 ET

SHOUCHENG: DATE OF BOARD MEETING

HKEXMay 2 05:02 ET · Announcements

Chinese humanoid robots are seizing a global $5 trillion "big track"!

Morgan Stanley expects that by 2050, a total of 1 billion humanoid robots will be deployed globally, with annual revenue reaching 4.7 trillion dollars, nearly double the total revenue of the top 20 global Auto Manufacturers in 2024. China's policy support, technological advancements, and manufacturing foundation place it in a leading position in the field of humanoid robots, especially in the Hardware supply chain.

wallstreetcnApr 29 08:19 ET

Is Shoucheng Holdings Limited's (HKG:697) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Simply Wall StApr 28 19:48 ET

Hong Kong stock announcement for treasure hunting | Aluminum Corporation Of China reported a net profit attributable to shareholders of approximately 3.538 billion yuan in the first quarter, a year-on-year increase of 58.78%.

SANDS CHINA LTD (01928) reported a total net income for the first quarter that decreased by 5.7% year-on-year to 1.7 billion dollars; SINO BIOPHARM (01177): 45 research achievements will be announced at the 2025 ASCO annual meeting.

Zhitong FinanceApr 24 11:00 ET